175 related articles for article (PubMed ID: 28596586)
1. Storage of neural histamine and histaminergic neurotransmission is VMAT2 dependent in the zebrafish.
Puttonen HAJ; Semenova S; Sundvik M; Panula P
Sci Rep; 2017 Jun; 7(1):3060. PubMed ID: 28596586
[TBL] [Abstract][Full Text] [Related]
2. Reserpine- and tetrabenazine-sensitive transport of (3)H-histamine by the neuronal isoform of the vesicular monoamine transporter.
Erickson JD; Eiden LE; Schafer MK; Weihe E
J Mol Neurosci; 1995; 6(4):277-87. PubMed ID: 8860238
[TBL] [Abstract][Full Text] [Related]
3. Transport of histamine by vesicular monoamine transporter-2.
Merickel A; Edwards RH
Neuropharmacology; 1995 Nov; 34(11):1543-7. PubMed ID: 8606801
[TBL] [Abstract][Full Text] [Related]
4. Transport and inhibition mechanisms of human VMAT2.
Wu D; Chen Q; Yu Z; Huang B; Zhao J; Wang Y; Su J; Zhou F; Yan R; Li N; Zhao Y; Jiang D
Nature; 2024 Feb; 626(7998):427-434. PubMed ID: 38081299
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of neurotransmitter transport and drug inhibition in human VMAT2.
Pidathala S; Liao S; Dai Y; Li X; Long C; Chang CL; Zhang Z; Lee CH
Nature; 2023 Nov; 623(7989):1086-1092. PubMed ID: 37914936
[TBL] [Abstract][Full Text] [Related]
6. Transport and inhibition mechanism for VMAT2-mediated synaptic vesicle loading of monoamines.
Wang Y; Zhang P; Chao Y; Zhu Z; Yang C; Zhou Z; Li Y; Long Y; Liu Y; Li D; Wang S; Qu Q
Cell Res; 2024 Jan; 34(1):47-57. PubMed ID: 38163846
[TBL] [Abstract][Full Text] [Related]
7. The histaminergic system regulates wakefulness and orexin/hypocretin neuron development via histamine receptor H1 in zebrafish.
Sundvik M; Kudo H; Toivonen P; Rozov S; Chen YC; Panula P
FASEB J; 2011 Dec; 25(12):4338-47. PubMed ID: 21885652
[TBL] [Abstract][Full Text] [Related]
8. Embryonic exposure to valproic acid affects the histaminergic system and the social behaviour of adult zebrafish (Danio rerio).
Baronio D; Puttonen HAJ; Sundvik M; Semenova S; Lehtonen E; Panula P
Br J Pharmacol; 2018 Mar; 175(5):797-809. PubMed ID: 29235100
[TBL] [Abstract][Full Text] [Related]
9. Protective actions of the vesicular monoamine transporter 2 (VMAT2) in monoaminergic neurons.
Guillot TS; Miller GW
Mol Neurobiol; 2009 Apr; 39(2):149-70. PubMed ID: 19259829
[TBL] [Abstract][Full Text] [Related]
10. Normal biogenesis and cycling of empty synaptic vesicles in dopamine neurons of vesicular monoamine transporter 2 knockout mice.
Croft BG; Fortin GD; Corera AT; Edwards RH; Beaudet A; Trudeau LE; Fon EA
Mol Biol Cell; 2005 Jan; 16(1):306-15. PubMed ID: 15496457
[TBL] [Abstract][Full Text] [Related]
11. Vesicular monoamine transporter 2 (SLC18A2) regulates monoamine turnover and brain development in zebrafish.
Baronio D; Chen YC; Decker AR; Enckell L; Fernández-López B; Semenova S; Puttonen HAJ; Cornell RA; Panula P
Acta Physiol (Oxf); 2022 Jan; 234(1):e13725. PubMed ID: 34403568
[TBL] [Abstract][Full Text] [Related]
12. VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse.
Eiden LE; Weihe E
Ann N Y Acad Sci; 2011 Jan; 1216():86-98. PubMed ID: 21272013
[TBL] [Abstract][Full Text] [Related]
13. Subcellular distribution of histamine, GABA and galanin in tuberomamillary neurons in vitro.
Kukko-Lukjanov TK; Panula P
J Chem Neuroanat; 2003 Jul; 25(4):279-92. PubMed ID: 12842273
[TBL] [Abstract][Full Text] [Related]
14. Sorting of vesicular monoamine transporter 2 to the regulated secretory pathway confers the somatodendritic exocytosis of monoamines.
Li H; Waites CL; Staal RG; Dobryy Y; Park J; Sulzer DL; Edwards RH
Neuron; 2005 Nov; 48(4):619-33. PubMed ID: 16301178
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of VMAT2 by β2-adrenergic agonists, antagonists, and the atypical antipsychotic ziprasidone.
Støve SI; Skjevik ÅA; Teigen K; Martinez A
Commun Biol; 2022 Nov; 5(1):1283. PubMed ID: 36418492
[TBL] [Abstract][Full Text] [Related]
16. The molecular chaperone Hsc70 interacts with the vesicular monoamine transporter-2.
Requena DF; Parra LA; Baust TB; Quiroz M; Leak RK; Garcia-Olivares J; Torres GE
J Neurochem; 2009 Jul; 110(2):581-94. PubMed ID: 19457116
[TBL] [Abstract][Full Text] [Related]
17. Localization and dynamic regulation of biogenic amine transporters in the mammalian central nervous system.
Hoffman BJ; Hansson SR; Mezey E; Palkovits M
Front Neuroendocrinol; 1998 Jul; 19(3):187-231. PubMed ID: 9665836
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Discovery of Arylpiperidinylquinazolines: New Inhibitors of the Vesicular Monoamine Transporter.
Provencher BA; Eshleman AJ; Johnson RA; Shi X; Kryatova O; Nelson J; Tian J; Gonzalez M; Meltzer PC; Janowsky A
J Med Chem; 2018 Oct; 61(20):9121-9131. PubMed ID: 30240563
[TBL] [Abstract][Full Text] [Related]
19. Vesicular monoamine transporter 2 (Vmat2) knockdown elicits anxiety-like behavior in zebrafish.
Wang Y; Li S; Liu W; Wang F; Hu LF; Zhong ZM; Wang H; Liu CF
Biochem Biophys Res Commun; 2016 Feb; 470(4):792-7. PubMed ID: 26801555
[TBL] [Abstract][Full Text] [Related]
20. A Novel Developmental Role for Dopaminergic Signaling to Specify Hypothalamic Neurotransmitter Identity.
Chen YC; Semenova S; Rozov S; Sundvik M; Bonkowsky JL; Panula P
J Biol Chem; 2016 Oct; 291(42):21880-21892. PubMed ID: 27539857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
